UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Improving valuation sampling of EQ-5D health states

Health and quality of life outcomes, 2013-01, Vol.11 (1), p.14-14

Bagust, Adrian

2013

Link zum Volltext

Verfügbarkeit prüfen

The average body surface area of adult cancer patients in the UK: a multicentre retrospective study

PloS one, 2010-01, Vol.5 (1), p.e8933-e8933

2010

Link zum Volltext

Verfügbarkeit prüfen

Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation

Health technology assessment (Winchester, England), 2020-01, Vol.24 (2), p.1-180

2020

Link zum Volltext

Verfügbarkeit prüfen

Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis

Health technology assessment (Winchester, England), 2015-04, Vol.19 (29), p.1-130

2015

Link zum Volltext

Verfügbarkeit prüfen

Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation

Health technology assessment (Winchester, England), 2015-06, Vol.19 (47), p.1-134

2015

Link zum Volltext

Verfügbarkeit prüfen

Eribulin for the Treatment of Advanced or Metastatic Breast Cancer: A NICE Single Technology Appraisal

PharmacoEconomics, 2015-02, Vol.33 (2), p.137-148

2015

Link zum Volltext

Verfügbarkeit prüfen

Docetaxel in Combination With Doxorubicin and Cyclophosphamide As Adjuvant Treatment for Early Node-Positive Breast Cancer: A Cost-Effectiveness and Cost-Utility Analysis

Journal of clinical oncology, 2008-02, Vol.26 (6), p.925-933

2008

Link zum Volltext

Verfügbarkeit prüfen

The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature

Health economics, 2001-10, Vol.10 (7), p.601-615

2001

Link zum Volltext

Verfügbarkeit prüfen

A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer

Thorax, 2015-04, Vol.70 (4), p.359-367

2015

Link zum Volltext

Verfügbarkeit prüfen

Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data

Health economics, 2005-03, Vol.14 (3), p.217-230

2005

Link zum Volltext

Verfügbarkeit prüfen

Exploring the Effects of Early Censoring and Analysis of Clinical Trial Survival Data on Effectiveness and Cost-effectiveness Estimation through a Case Study in Advanced Breast Cancer

Medical decision making, 2018-10, Vol.38 (7), p.789-796

2018

Link zum Volltext

Verfügbarkeit prüfen

Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes

Cochrane database of systematic reviews, 2010-05 (5), p.CD004587

2010

Link zum Volltext

Verfügbarkeit prüfen

Pertuzumab in Combination with Trastuzumab and Docetaxel for the Treatment of HER2-Positive Metastatic or Locally Recurrent Unresectable Breast Cancer

PharmacoEconomics, 2015-01, Vol.33 (1), p.13-23

2015

Link zum Volltext

Verfügbarkeit prüfen

Dynamics of bed use in accommodating emergency admissions: stochastic simulation model

BMJ (Online), 1999-07, Vol.319 (7203), p.155

1999

Link zum Volltext

Verfügbarkeit prüfen

Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics, 2018-03, Vol.36 (3), p.289-299

2018

Link zum Volltext

Verfügbarkeit prüfen

Computer modeling of Diabetes and its Complications: A report on the Fourth Mount Hood Challenge meeting

Diabetes care, 2007-06, Vol.30 (6), p.1638-1646

2007

Link zum Volltext

Verfügbarkeit prüfen

Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics, 2017-10, Vol.35 (10), p.1035-1046

2017

Link zum Volltext

Verfügbarkeit prüfen

Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group Perspective

PharmacoEconomics, 2015-09, Vol.33 (9), p.893-904

2015

Link zum Volltext

Verfügbarkeit prüfen

Vemurafenib for the Treatment of Locally Advanced or Metastatic BRAF V600 Mutation-Positive Malignant Melanoma: A NICE Single Technology Appraisal

PharmacoEconomics, 2013-12, Vol.31 (12), p.1121-1129

2013

Link zum Volltext

Verfügbarkeit prüfen

Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy: A NICE Single Technology Appraisal

PharmacoEconomics, 2011-12, Vol.29 (12), p.1051-1062

2011

Link zum Volltext

Verfügbarkeit prüfen

Rituximab for the First-Line Maintenance Treatment of Follicular Non-Hodgkin’s Lymphoma: A NICE Single Technology Appraisal

PharmacoEconomics, 2013-01, Vol.31 (5), p.403-413

2013

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: A NICE Single Technology Appraisal

PharmacoEconomics, 2010-01, Vol.28 (6), p.439-448

2010

Link zum Volltext

Verfügbarkeit prüfen

Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics - open, 2019-09, Vol.3 (3), p.293-302

2019

Link zum Volltext

Verfügbarkeit prüfen

Population screening for lung cancer using computed tomography, is there evidence of clinical effectiveness? A systematic review of the literature

Thorax, 2007-02, Vol.62 (2), p.131-138

2007

Link zum Volltext

Verfügbarkeit prüfen

Guidelines for Computer Modeling of Diabetes and Its Complications

Diabetes care, 2005-02, Vol.28 (2), p.500-500

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(62)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Improving valuation sampling of EQ-5D health states

The average body surface area of adult cancer patients in the UK: a multicentre retrospective study

Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation

Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis

Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation

Eribulin for the Treatment of Advanced or Metastatic Breast Cancer: A NICE Single Technology Appraisal

Docetaxel in Combination With Doxorubicin and Cyclophosphamide As Adjuvant Treatment for Early Node-Positive Breast Cancer: A Cost-Effectiveness and Cost-Utility Analysis

The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature

A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer

Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data

Exploring the Effects of Early Censoring and Analysis of Clinical Trial Survival Data on Effectiveness and Cost-effectiveness Estimation through a Case Study in Advanced Breast Cancer

Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes

Pertuzumab in Combination with Trastuzumab and Docetaxel for the Treatment of HER2-Positive Metastatic or Locally Recurrent Unresectable Breast Cancer

Dynamics of bed use in accommodating emergency admissions: stochastic simulation model

Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Computer modeling of Diabetes and its Complications: A report on the Fourth Mount Hood Challenge meeting

Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group Perspective

Vemurafenib for the Treatment of Locally Advanced or Metastatic BRAF V600 Mutation-Positive Malignant Melanoma: A NICE Single Technology Appraisal

Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy: A NICE Single Technology Appraisal

Rituximab for the First-Line Maintenance Treatment of Follicular Non-Hodgkin’s Lymphoma: A NICE Single Technology Appraisal

Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: A NICE Single Technology Appraisal

Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Population screening for lung cancer using computed tomography, is there evidence of clinical effectiveness? A systematic review of the literature

Guidelines for Computer Modeling of Diabetes and Its Complications

Suchergebnisse filtern